Commodore Capital LP boosted its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 6.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 610,000 shares of the biotechnology company’s stock after buying an additional 35,000 shares during the period. Arrowhead Pharmaceuticals accounts […]
Commodore Capital LP grew its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 6.1% during the second quarter, Holdings Channel.com reports. The fund owned 610,000 shares of the biotechnology company’s stock after purchasing an additional 35,000 shares during the quarter. Arrowhead Pharmaceuticals makes up 2.4% of Commodore Capital LP’s investment portfolio, making the […]
Bank of America assumed coverage on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research report released on Monday, Marketbeat.com reports. The firm issued a buy rating and a $29.00 price objective on the biotechnology company’s stock. ARWR has been the subject of several other research reports. Royal Bank of Canada restated an […]
Research analysts at Bank of America began coverage on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) in a research report issued on Monday, Briefing.com reports. The firm set a “buy” rating and a $29.00 price target on the biotechnology company’s stock. Bank of America‘s target price suggests a potential upside of 25.16% from […]
By Ben Glickman Shares of Arrowhead Pharmaceuticals rose Monday after the company gained a new bull in Bank of America Securities analysts. The stock was up.